Skip to main content
BoF Logo

Agenda-setting intelligence, analysis and advice for the global fashion community.

Novo Nordisk Launches Wegovy Weight-Loss Pill in US, Triggering Price War

The first and only GLP-1 pill on the market costs significantly less than injectable versions.
Novo Nordisk HQ.
Novo Nordisk’s share price rose by more than 4 percent on Monday, but is still down by 44 percent over the past year amid fierce competition from rivals. (Shutterstock)

The first pill version of the blockbuster GLP-1 weight loss drugs has been launched in the US by

Please sign in to ensure you can read our agenda-setting intelligence, analysis and advice. Or get in touch at support@businessoffashion.com if you experience difficulties.

© 2026 The Business of Fashion. All rights reserved. For more information read our Terms & Conditions

More from Beauty
Analysis and advice on the fast-evolving beauty business.
view more
Latest News & Analysis
Unrivalled, world class journalism across fashion, luxury and beauty industries.

The Industry That Eats Its Young

Small fashion labels have always been shortchanged by their wholesale partners. A wave of high-profile bankruptcies has turned a structural injustice into an existential crisis. There is a better way to do business, writes Imran Amed.


The Zara-Fication of John Galliano

Fashion’s enfant terrible is trading exclusivity for the mass market. Is it the ultimate fashion coup, or the final surrender of prestige?


The Impact of War on Fashion’s Supply Chain

Textile hubs are already feeling the cascading risks of the conflict in Iran as Washington ramps up forced labour probes to revive tariffs, while decarbonisation in fashion’s factories might finally have a standard to go off of.


VIEW MORE
Agenda-setting intelligence, analysis and advice for the global fashion community.
CONNECT WITH US ON